Description
What is adagrasib?
Adagrasib (sold under the brand name Krazati) is an oral, targeted precision cancer therapy that acts as an irreversible and selective covalent inhibitor of the KRAS G12C mutation.
It Treats
• Non-Small Cell Lung Cancer (NSCLC): Used as a single agent in adults with locally advanced or metastatic KRAS G12C-mutated NSCLC who have received at least one prior systemic therapy.
• Colorectal Cancer (CRC): Used in combination with cetuximab (Erbitux) in adults with KRAS G12C-mutated colorectal cancer that has spread after prior systemic treatment.
Contact Sourcing Facilitation Team
Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com
Krazati (Adagrasib) Price in India: Availability and Cost
Availability Status:
Krazati is an internationally manufactured specialty oncology medication. Krazati is not officially registered or commercially available for standard retail sale in India, meaning it does not have a fixed Maximum Retail Price (MRP) in India.
Cost Factors:
- The price of imported specialty medications fluctuates based on international currency exchange rates, import duties, shipping fees, and dosage requirements.
- For precise, real-time pricing and stock availability per bottle/pack, patients and caregivers must connect directly with licensed international pharmaceutical distributors or authorized Named Patient facilitators.
Where to Buy Adagrasib (Krazati) in Delhi, India?
From Specialty Pharmaceutical Importers & Global Sourcing:
- Licensed specialty medicine distributors and international sourcing agencies – South Delhi Pharma (headquartered in New Delhi with delivery networks covering Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Aurangabad, Pune, Bengaluru, Hyderabad, Chennai, Visakhapatnam, Coimbatore, and other regions of India – facilitate access to specialized oncology treatments.
- SDP act as Named Patient Program (NPP) facilitators, helping patients and hospitals legally coordinate the procurement and delivery of non-locally approved or imported therapies.
Named Patient Supply (NPS) & Import Channels:
Because specialized targeted therapies like Krazati are frequently sourced from international markets (such as the US or Europe) for personal medical use, patients can coordinate orders through authorized cross-border medical sourcing platforms and licensed specialty distributors.
Required Documentation for Compliance:
To legally purchase and import Krazati for patient use in compliance with regulations, authorized suppliers typically require:
- A valid, original prescription issued by a registered medical oncologist.
- Supporting diagnostic or pathology reports.
- Valid patient identification proof and adherence to local personal import and customs guidelines.
Disclaimer: Krazati (Adagrasib) is a prescription drug. All procurement inquiries must be accompanied by legitimate medical credentials and valid oncology prescriptions.
Note: South Delhi Pharma, act as a facilitation partner and do not manufacture, sell, or distribute pharmaceutical products. All facilitation activities are conducted in accordance with applicable Indian pharmaceutical and trade regulations.
